Laboratory Corporation of America Holdings
Compositions and Methods for Identifying Subjects Who May Benefit From Treatment With Therapeutic Agents

Last updated:

Abstract:

Disclosed herein are compositions and methods for the identification of subjects who are likely to benefit from use of a therapeutic agent. The present invention utilizes the specificity of therapeutic monoclonal antibodies for a single epitope to determine whether a therapeutic monoclonal antibody interacts with biological material in/from a patient.

Status:
Application
Type:

Utility

Filling date:

27 Mar 2019

Issue date:

3 Oct 2019